Back to search
Secondarily Infected Traumatic Lesions (SITL)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Secondarily Infected Traumatic Lesions (SITL) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Secondarily Infected Traumatic Lesions (SITL) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
A national, prospective single arm phase II study investigating the pharmacokinetics and safety of the 2% TD1414 cream when applied 3 times daily for 7 days to…
An international, multi-centre, prospective three arm parallel-group, phase II proof of concept study comparing the efficacy and safety of two dosage regimens (…
The purpose of this study is to provide further evidence of the clinical and bacteriological efficacy of retapamulin in the treatment of subjects with SITL or i…
The purpose of Study TOC110977 is to demonstrate clinical superiority of Retapamulin ointment, 1%, over placebo in patients with secondarily-infected traumatic…